214 related articles for article (PubMed ID: 9123929)
1. An easy dipstick assay for anti-core antibodies to screen blood donors for hepatitis C virus viremia.
Mulyanto ; Suwignyo S; Tsauri S; Itoh K; Mizui M; Tsuda F; Okamoto H; Yoshizawa H; Mishiro S
Vox Sang; 1996; 70(4):229-31. PubMed ID: 9123929
[No Abstract] [Full Text] [Related]
2. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
3. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
Alvarez M; Planelles D; Vila E; Montoro J; Franco E
Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
[No Abstract] [Full Text] [Related]
4. Hepatitis C virus RNA positivity among RIBA-3 indeterminates.
Jha J; Arankalle VA; Banerjee K
Vox Sang; 1995; 69(2):145-6. PubMed ID: 8585200
[No Abstract] [Full Text] [Related]
5. Anti-GOR without anti-HCV core is not associated with hepatitis C viremia.
Bååth L; Widell A
Vox Sang; 1994; 66(2):151. PubMed ID: 7514327
[No Abstract] [Full Text] [Related]
6. [Interpretation of hepatitis C virus serology: immunoblot and genome amplification].
Maniez-Montreuil M; Dubois F
Transfus Clin Biol; 2000 Jun; 7 Suppl 1():25s-30s. PubMed ID: 10919220
[TBL] [Abstract][Full Text] [Related]
7. NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.
Andrea P; Kupek E; Genovez G; Martins JT; Barban GB
Transfus Med; 2015 Apr; 25(2):125-7. PubMed ID: 25720742
[No Abstract] [Full Text] [Related]
8. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
Laperche S; Bouchardeau F; Maniez M; Béolet M; Elghouzzi MH; Lefrère JJ
Vox Sang; 2004 Apr; 86(3):198. PubMed ID: 15078255
[No Abstract] [Full Text] [Related]
9. Incidence of hepatitis C virus RNA in anti-HCV-negative plasma pools and blood products.
Saldanha J; Minor P
Vox Sang; 1996; 70(4):232-4. PubMed ID: 9123930
[No Abstract] [Full Text] [Related]
10. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations.
Lee SR; Peterson J; Niven P; Bahl C; Page E; DeLeys R; Giordano-Schmidt D; Baggett D; Green G
Vox Sang; 2001 Jan; 80(1):19-23. PubMed ID: 11339063
[TBL] [Abstract][Full Text] [Related]
12. HCV positivity rate in the seronegative blood donors in China.
Yang Z; Han YX; Jiang JD; Yang Z; Yu YX; Qiu Y
Biomed Pharmacother; 2009 May; 63(4):319-20. PubMed ID: 19246175
[No Abstract] [Full Text] [Related]
13. The value of HCV antigen test with reference to PCR in confirming infection in cases with indefinite antibody test result.
Seiskari T; Horsti J; Aittoniemi J
J Clin Virol; 2011 May; 51(1):90-1. PubMed ID: 21377410
[No Abstract] [Full Text] [Related]
14. [Serological and molecular markers of HCV infection in Polish blood donors].
Brojer E
Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
[TBL] [Abstract][Full Text] [Related]
15. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
León P; Echevarría JM
Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
[No Abstract] [Full Text] [Related]
16. [Screening for HCV core antigen among HIV-positive patients infected by sexual transmission].
Dubrous P; Hugard L; Terrier F
Med Mal Infect; 2004 May; 34(5):236-8. PubMed ID: 16235605
[No Abstract] [Full Text] [Related]
17. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
18. Use of the Procleix HIV-1 and HCV discriminatory assays to detect HIV and HCV RNA in whole blood.
Tobler LH; Dockter J; Stramer SL; Kleinman SH; Todd D; Giachetti C; Busch MP
Transfusion; 2002 Nov; 42(11):1525-7. PubMed ID: 12421231
[No Abstract] [Full Text] [Related]
19. Implementation of an 'in-house' PCR assay validated for the detection of hepatitis C virus RNA.
Lombardi GR; Oviedo A; Freytes F; Zarzur J; Guglielmone H; Vitali MS
Transfus Med; 2008 Oct; 18(5):317-9. PubMed ID: 18937742
[No Abstract] [Full Text] [Related]
20. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
